You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-Survivin 2B antibody (ab3729)

CodeSizePriceAbpointsAvailability
    
Add to basket
 

  • -

  •   
  •   
  •   

  •  

  •  
  •  

  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Publishing research using ab3729? Please let us know so that we can cite the reference in this datasheet

Show applications key

ab3729 has been referenced in 4 publications.

  1. Small TW & Pickering JG Nuclear degradation of Wilms tumor 1-associating protein and survivin splice variant switching underlie IGF-1-mediated survival. J Biol Chem 284:24684-95 (2009). WB; Human. PubMed: 19605357
  2. Végran F et al. Association of p53 gene alterations with the expression of antiapoptotic survivin splice variants in breast cancer. Oncogene 26:290-7 (2007). PubMed: 16847456
  3. Noton EA et al. Molecular analysis of survivin isoforms: evidence that alternatively spliced variants do not play a role in mitosis. J Biol Chem 281:1286-95 (2006). PubMed: 16291752
  4. Caldas H et al. Survivin splice variants regulate the balance between proliferation and cell death. Oncogene 24:1994-2007 (2005). PubMed: 15688031

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"